VK2735 met its primary endpoint but failed to outdo competitors Novo Nordisk and Eli Lilly in terms of body weight loss.

Viking Therapeutics has experienced a significant drop in its stock price over the past week, plummeting by 38.23%. This sharp decline follows the release of data from a Phase 2 clinical trial for ...

FI's stablecoin launch with PayPal and a solid growth outlook show promise, but profitability and competition pose challenges ...

New Fortress Energy finds itself navigating a severe financial storm, characterized by a Nasdaq compliance notice, a burdensome debt load, and a steep decline in its share price, painting a concerning ...

Helen of Troy's market value plummets as U.S. tariffs against China continue to hurt El Paso consumer products company's ...

Snap stock plummeted Wednesday after its Q2 earnings and revenue missed Wall Street's estimates the previous day.

The company revealed it has entered into a securities purchase agreement with institutional investors to sell 3,225,000 shares of common stock at $1.20 per share. The offering, expected to close on ...

The S&P 500 lost five days in a row, extending its declines on fears regarding the economy and company earnings reports. The index declined by 0.3%, with te ...

The company priced its offering of 3.5 million shares of common stock at $2.00 per share, raising $7 million in gross proceeds before deducting underwriting discounts and expenses. Vision Marine also ...

Investing.com -- enVVeno Medical (TASE: BLWV) Corporation (NASDAQ: NVNO) stock plummeted 70% after the company received a not-approvable letter from the U.S. Food and Drug Administration for its ...

U.S. stock futures are pointing higher after indexes rebounded yesterday from last week's selloff and investors watch for more corporate earnings. Here's what investors need to know today.